# Daniel van den Bergh

> Daniel van den Bergh is a Series B investor at Endeavour Vision backing Health Care and Software. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Endeavour Vision](https://shizune.co/investors/profile/endeavour-vision)
- Location: San Francisco Bay Area, United States
- Total investments: 3
- Last investment: Sep 2025
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/danielvdb/

Daniel van den Bergh is a Series B investor at Endeavour Vision in San Francisco Bay Area focused on Health Care and Software. Daniel van den Bergh is the Senior Investment Director at Endeavour Vision. Daniel van den Bergh attended at University of Pennsylvania - The Wharton School.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 67% |
| Software | 1 | 33% |
| Wellness | 1 | 33% |
| InsurTech | 1 | 33% |
| Therapeutics | 1 | 33% |

12 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 2 | 67% |
| Series A | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| SureCo | Rebuilding American Health Care through ICHRA | $23M | Series A | Sep 30, 2025 |  |
| NOCD | NOCD is an online OCD therapy platform that helps people with OCD get better and then stay better. With NOCD, users can have face-to-face video therapy sessions with licensed therapists that specialize in OCD, as well as get 24/7 support between sessions from self-help tools and peer communities. | $33M | Series B | Sep 21, 2021 |  |
| Ordr | Ordr makes it easy to secure every connected device, from traditional IT devices to newer and more vulnerable IoT, IoMT, and OT. Ordr uses deep packet inspection and advanced machine learning to discover every device, profile its risk and behavior, map all communications and protect it with automated policies. Organizations worldwide trust Ordr toprovide real-time asset inventory, address risk and compliance and accelerate IT initiatives. Ordr is backed by top investors including Battery Ventures, Wing, and TenEleven Ventures. | $6M | Series B | Mar 05, 2020 |  |

3 of 3 investments shown.

## Co-investors
- [7wire Ventures](https://shizune.co/investors/profile/7wire-ventures) — VC Fund, 2 deals together
- [Chicago Ventures](https://shizune.co/investors/profile/chicago-ventures) — VC Fund, 2 deals together
- [Eight Roads Ventures](https://shizune.co/investors/profile/eight-roads-ventures) — VC Fund, 1 deal together
- [F-Prime](https://shizune.co/investors/profile/f-prime-capital-partners) — VC Fund, 1 deal together
- [Health Enterprise Partners](https://shizune.co/investors/profile/health-enterprise-partners) — VC Fund, 1 deal together
- [Health Velocity Capital](https://shizune.co/investors/profile/health-velocity-capital) — VC Fund, 1 deal together

## About Endeavour Vision

VC Fund · Geneva, Switzerland

Endeavour Vision is a private equity firm investing in growth-stage MedTech and digital health companies. The company invests in medical innovation that provides superior clinical benefits for patients or brings significant efficiencies to health systems. Endeavour Vision team offers strategic and operational expertise and extensive internationalexperience investing in companies in Europe and North America. We have a proven track record of successful exits with recently realized investments that include Vertiflex (acquired by Boston Scientific in 2019), Medartis (IPO on SIX in Q1 2018), and Symetis (acquired by Boston Scientific in 2017). Endeavour Vision’s offices are located in Geneva, Switzerland, and Minneapolis, U.S.

5 contacts available at Endeavour Vision.

| Name | Title | Profile |
| --- | --- | --- |
| Alex Schmitz | Partner | https://shizune.co/investors/profile/alex-schmitz-2 |
| Bernard Vogel | Founder and Managing Partner | https://shizune.co/investors/profile/bernard-vogel |
| Damien Tappy | President & Managing Partner | https://shizune.co/investors/profile/damien-tappy |
| Daniel van den Bergh | Senior Investment Director | https://shizune.co/investors/profile/daniel-van-den-bergh |
| Fernando Pacheco | Investment Director | https://shizune.co/investors/profile/fernando-pacheco |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Daniel van den Bergh invest in?

Daniel van den Bergh invests primarily in Health Care, Software and Wellness startups, most often at Series B and Series A stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Daniel van den Bergh last invest?

The most recent investment recorded for Daniel van den Bergh closed in Sep 2025. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co